Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Clinical trial NCT06861192 · RECRUITING
Trial details
- NCT number
- NCT06861192
- Sponsor
- baotai Liang
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-16
- Primary completion
- 2026-03-16
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.